HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Seeks $19 Mil. From Cosmetics Firms In User-Fee-Heavy 2014 Budget

This article was originally published in The Rose Sheet

Executive Summary

Collecting user fees from cosmetics manufacturers to the tune of $19 million would help “improve FDA’s capacity to promote greater safety and understanding of cosmetic products,” the agency says. FDA submitted a similar proposal last year and will be up against challenges again in securing the necessary legislation.

You may also be interested in...



In Brief: FDA Requests Cosmetics User Fees; Walmart On Ingredient Disclosure

The Obama Administration’s proposed budget for fiscal 2015 includes $19 million to be derived from cosmetics user fees. Walmart offers more detail on its Policy for Sustainable Chemistry in Consumables. More news in brief.

FDA Gets $91 Million Boost, Sequestered User Fees In 2014 Appropriation

A 2014 omnibus appropriations bill agreed to by Senate and House appropriators would give FDA $2.55 billion in discretionary funding, a $91 million increase. The bill would also make available $85 million in previously sequestered FDA user fees.

FDA’s Cosmetics Site Relaunching In 2014 To Promote Education

FDA is “reinvesting” in its cosmetics website (FDA.gov/Cosmetics) to enhance data available to companies and consumers, says Center for Food Safety and Applied Nutrition’s Office of Cosmetics and Colors. Spokesperson says site is scheduled to relaunch in mid-2014.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel